万杰颂 Jason Mann M.D.

Jason Mann, MD, PhD, has a diverse and extensive work experience in the healthcare industry. Jason is currently serving as the Asia Healthcare Lead at Guidepoint since 2019. In 2021, they joined PING AN as the Managing Director of the Ping An Global Voyager Fund / Voyager Partners, specializing in healthcare investments with a focus on digital health and diagnostics opportunities in the US and Europe.

Dr. Mann also holds the position of Senior Advisor / Venture Partner at Eight Roads since 2021. In addition, they are the Managing Director of ProMed Advisors since 2010, where they utilize their extensive background in Asia and over 30 years of healthcare experience to invest and build international healthcare businesses. Jason has advised and invested in over 100 life science and healthcare companies, with a particular focus on Asia healthcare and global biotech/medtech.

Outside of these roles, Dr. Mann has served as a Strategic Advisor to Global Healthcare/Life Science CEOs and Boards of Directors in multiple confidential companies since 2008. Jason has also acted as a Strategic Advisor to the CEO of Pascal Metrics since 2020, and as a Strategic Advisor to the Managing Partners of Novo Ventures and Novo Holdings from 2019 to 2021.

Furthermore, Dr. Mann has worked as a Strategic Advisor to the CEO and other senior management at MCM Partners from 2019 to 2020. Jason served as a Strategic Advisor to the CEO and Board of Aleva Neurotherapeutics SA from 2018 to 2020, with a strong focus on the Asian market. Similarly, they held the position of Strategic Advisor to the CEO and other senior management at Phase Scientific International Limited from 2018 to 2020.

Overall, Dr. Jason Mann's work experience showcases their expertise in healthcare investment, international business development, and strategic advisory roles in the healthcare and life sciences sectors.

Jason Mann MD, PhD 万杰颂 pursued their undergraduate studies at Harvard University, where they obtained an A.B. degree in East Asian Studies / Pre-Medicine. Jason then went on to pursue a Ph.D. in Cancer Biology at Vanderbilt University. Subsequently, they completed their medical education at Vanderbilt University School of Medicine and obtained their Doctor of Medicine (MD) degree.